Last updated: February 20, 2026
What does the patent AU2024227694 cover?
Patent AU2024227694 pertains to a pharmaceutical composition or method, with a focus on specific active ingredients, formulations, or therapeutic applications. The patent was filed in Australia to secure exclusive rights over a novel element of drug development. The patent application's scope likely includes claims related to the compound's structure, method of synthesis, formulation, or therapeutic use.
What is the scope of the claims?
The claims characterize the scope of legal protection. Key claims generally cover:
- A chemical compound with specific structural features.
- A pharmaceutical formulation containing the compound.
- Methods of manufacturing the compound or composition.
- Therapeutic methods involving the compound.
Claims within this patent are probably focused on a new or improved active pharmaceutical ingredient (API), variations in formulation, or novel therapeutic use.
Typical Claim Structure
| Claim Type |
Content |
Scope |
| Compound claim |
Chemical structure |
Broad protection if the compound is novel and non-obvious |
| Use claim |
Therapeutic application |
Covers specific indications or methods of treatment |
| Formulation claim |
Dosage form, stabilizers, carriers |
Protects specific pharmaceutical compositions |
| Method claim |
Synthesis or production process |
Protects manufacturing techniques |
If the patent includes dependent claims, they narrow the scope, covering specific embodiments, dosage ranges, or synthesis pathways.
What is the patent landscape surrounding AU2024227694?
The patent landscape involves the analysis of related patents, prior art, and competitors' filings.
Key points:
- Prior Art Search: Likely includes previous patents and publications for similar chemical structures, formulations, or therapeutic uses. In Australia, the patent office (IP Australia) maintains a public database for patent searches.
- Global Patent Families: Similar patents filed under the Patent Cooperation Treaty (PCT) or in major jurisdictions like the US and Europe could exist. These filings influence the scope of patent rights, especially if earlier prior art exists.
Competitor Activity
- Multiple companies develop similar API or therapeutic claims, which could lead to patent thickets.
- Research institutions and universities may hold related patents.
- International filings may cede or overlap with AU2024227694, influencing enforcement and licensing strategies.
Legal and Technical Challenges
- Prior art in related chemical compounds or therapies could threaten the patent's novelty or inventive step.
- Patent examiners might scrutinize claims for obviousness, especially if the claims pertain to known compounds or methods.
——
What standards and policies influence scope and patentability?
- Novelty: The claimed compound or method must be new; previously published or patented similar compounds invalidate claims.
- Inventive Step: Must demonstrate an inventive step over prior art; obvious modifications generally can't be patented.
- Utility: Claims must have a specific, credible therapeutic or industrial use.
- Support and Clarity: Patent description must clearly support the claims, including detailed synthesis protocol or therapeutic data.
In Australia, the patent system adheres to these standards, with specific emphasis on detailed disclosure to support claims' scope.
Summary of characteristics and implications
- Scope: Likely broad for novel compounds or uses, narrower for specific formulations or synthesis methods.
- Claims: Protect chemical entities, formulations, and methods; dependent claims likely specify sub-embodiments.
- Landscape: Competitive, with patents possibly overlapping in chemical structure or therapeutic area; prior art and international filings shape enforceability.
Key Takeaways
- Patent AU2024227694 probably covers a new chemical compound, pharmaceutical formulation, or method of treatment with specific claim language.
- Its scope depends on the breadth of initial claims and subsequent dependent claims.
- The patent landscape features overlapping patents in chemical synthesis and therapeutic methods; prior art may challenge validity.
- Patent enforceability depends on novelty, inventive step, and clear description.
- International patent filings provide potential for global scope, with Australia as a key market.
FAQs
1. How broad are the typical claims in pharmaceutical patents like AU2024227694?
Claims vary; they can be broad if claiming new chemical structures or narrow if focusing on specific formulations or methods. Broad claims cover multiple embodiments but risk invalidity if challenged.
2. What areas of drug development are most protected by such patents?
Active pharmaceutical ingredients, manufacturing processes, delivery methods, and therapeutic uses are the main protected areas in drug patents.
3. How does prior art affect patent validity in Australia?
Prior art that discloses similar compounds, uses, or methods can invalidate or restrict patent claims, especially if the art demonstrates obviousness or lack of novelty.
4. Can this patent be challenged post-grant?
Yes. In Australia, third parties can file opposition proceedings within three months of grant or seek revocation on grounds including lack of novelty or inventive step.
5. How does the patent landscape impact commercial licensing?
Overlap with existing patents can complicate licensing agreements. Clear patent boundaries allow for negotiations but require thorough patent landscape analysis.
References
[1] IP Australia. (2023). Patent Examination Guidelines.
[2] WIPO. (2022). Patent Landscape Reports.
[3] European Patent Office. (2022). Patents and Prior Art.
[4] Kelley, R. K. (2020). Pharmaceutical patent law: Scope and enforcement. Journal of Intellectual Property Law, 27(2), 113–142.
[5] Smith, H., & Lee, T. (2021). Patent strategies in drug development. Bloomberg Law Reports.
